# Extended Treatment for Smoking Cessation

> **NCT01330043** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 223 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Bupropion
- **DRUG:** Nicotine patch
- **DRUG:** Varenicline

## Key facts

- **NCT ID:** NCT01330043
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2017-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01330043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01330043, "Extended Treatment for Smoking Cessation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01330043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*